Atossa Therapeutics Inc.
Atossa Therapeutics Inc. (ATOS) — Form 8-K: Current report
About this filing
Atossa Therapeutics Inc. (ATOS) filed an 8-K on Oct 9, 2026 reporting entry into a material agreement (Item 1.01), a change to shareholder rights (Item 3.03) and other events (Item 8.01), with exhibits (Item 9.01).
Key facts
- Item 1.01 · Entry into a material agreement
- Item 3.03 · Change to shareholder rights
- Item 8.01 · Other events
- Item 9.01 · Financial statements and exhibits
More ATOS filings
- 8-K
Filed Nov 10, 2026
- 10-Q
Filed Nov 10, 2026
- 8-K
Filed Sep 29, 2026
- 8-K
Filed Sep 18, 2026
- 8-K
Filed Aug 7, 2026
- 10-Q
Filed Aug 7, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.